NFE2L2 and neoplasm: Recent studies have reported that NRF2 causes transcriptional and metabolic reprogramming in myeloid cells; high levels of NRF2 in TAMs inhibit their potential cytotoxicity on tumor cells and also impair T cell-mediated antitumor responses [46,47].